financetom
Business
financetom
/
Business
/
OpenAI CEO Sam Altman exits Helion Energy's board as firms explore partnership
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
OpenAI CEO Sam Altman exits Helion Energy's board as firms explore partnership
Mar 23, 2026 12:26 PM

March 23 (Reuters) - OpenAI Chief Executive Sam Altman

said on Monday he has stepped down from the board of directors

of Helion Energy, the fusion startup he has backed since 2015,

as the companies start to explore working together "at

significant scale".

Altman, who is also on the OpenAI board, said the dual roles

had become untenable as the ChatGPT maker eyes future

partnerships with Helion. In a post on social media platform X,

Altman added that he will have a financial interest in Helion

and will recuse himself from any deal negotiations.

"Sam has played an integral role in Helion's development...

I look forward to working with (Altman) in this new capacity,"

Helion CEO David Kirtley said in an X post separately.

OpenAI is also in advanced talks to buy electricity from

Helion Energy, Axios reported on Monday, citing a person

familiar with the situation.

Under the terms being discussed, OpenAI could secure a

guaranteed portion of Helion's production, initially 12.5%, with

talks centering on OpenAI receiving the equivalent of 5

gigawatts by 2030, scaling to 50 gigawatts by 2035, the report

added.

OpenAI did not immediately respond to Reuters request for

comment on the Axios report. A spokesperson for Helion said:

"beyond the previously announced deals with Microsoft ( MSFT ) and Nucor,

Helion has not made any new customer announcements."

A potential deal underscores a broader race among the

world's largest technology companies to lock in long-term energy

supplies as the explosive growth of artificial intelligence

strains power grids.

Microsoft ( MSFT ), Google, and Amazon ( AMZN )

have all struck deals with nuclear and fusion companies that

would have seemed far-fetched just a few years ago.

Helion was founded in 2013 by Kirtley, along with John

Slough, Chris Pihl, and George Votroubek. It has raised over $1

billion in total funding, with a $425 million Series F closed in

January 2025 that valued the company at $5.4 billion.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Telesat Selects Calian to Develop and Deploy Element Management System for Telesat Lightspeed Network
Telesat Selects Calian to Develop and Deploy Element Management System for Telesat Lightspeed Network
Sep 9, 2024
08:05 AM EDT, 09/09/2024 (MT Newswires) -- Telesat ( TSAT ) said Monday that it has selected Calian Group ( CLNFF ) , to design, manufacture and deploy the Element Management System within the Telesat Lightspeed Low Earth Orbit satellite network. Calian will also provide maintenance and support for the system. The EMS will connect and maintain operations for various...
Mobileye to Close Internal Lidar Development Program by Year-end
Mobileye to Close Internal Lidar Development Program by Year-end
Sep 9, 2024
08:05 AM EDT, 09/09/2024 (MT Newswires) -- Mobileye Global ( MBLY ) said Monday it will cease the internal development of next-generation frequency modulated continuous wave, or FMCW lidar for autonomous and highly automated driving systems by the end of the year. Mobileye said the FMCW lidar technology is now less essential to its roadmap for eyes-off systems due to...
Summit Therapeutics' Lung Cancer Candidate Surpasses Merck's Multi-Billion Dollar Keytruda, Cuts Risk Of Disease Or Death By Half
Summit Therapeutics' Lung Cancer Candidate Surpasses Merck's Multi-Billion Dollar Keytruda, Cuts Risk Of Disease Or Death By Half
Sep 9, 2024
Sunday, Summit Therapeutics Inc. ( SMMT ) released data from the primary analysis of the Phase 3 HARMONi-2 trial of ivonescimab conducted in China, sponsored by collaboration partner Akeso, Inc. The data was presented at the International Association for the Study of Lung Cancer’s 2024 World Conference on Lung Cancer. The trial evaluated monotherapy ivonescimab against monotherapy Merck ( MRK...
Canada's Slack Attack Intensifies, Says Rosenberg Research
Canada's Slack Attack Intensifies, Says Rosenberg Research
Sep 9, 2024
08:02 AM EDT, 09/09/2024 (MT Newswires) -- Employment grew by 22,199 in Canada in August on a seasonally adjusted basis in Friday's Labour Force Survey, recovering from the 2,800 contraction seen in July by almost the margin anticipated by forecasters as consensus was for 25, 000 gains, noted Rosenberg Research. That's where the good news ends, said Rosenberg Research. Full-time...
Copyright 2023-2026 - www.financetom.com All Rights Reserved